Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Medical Grade Honey (L-Mesitran) for Cervical Intraepithelial Neoplasia-II

NCT06219018 is registered in ClinicalTrials.gov with Zuyderland Medisch Centrum as lead sponsor.

NCT NCT06219018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06219018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Medical Grade Honey (L-Mesitran) for Cervical Intraepithelial Neoplasia-II
Lead sponsor
Zuyderland Medisch Centrum
Phase
Phase 1/2
Overall status
Recruiting
Start date
December 30, 2024
Completion date
December 1, 2027
Enrollment
60 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia-ii, high risk human papillomavirus